Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-05-02 5:3:0 am | NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 2a Clinical Trial of DA-1241 for the Treatment of NASH | PRNewsWire |
| 2023-04-03 5:0:0 am | NeuroBo Pharmaceuticals Announces Submission of IND Application to the FDA for a Phase 2a Clinical Trial of DA-1241 for the Treatment of NASH | PR Newswire |
| 2023-03-30 1:40:0 pm | NeuroBo Pharmaceuticals Reports Full Year 2022 Financial Results | PR Newswire |
Please consider a small donation if you think this website provides you with relevant information